White label ELPA - ClinicalTrials.eu

Study of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma

Not recruiting

4 1 1 1
Investigated diseases:
- Squamous cell carcinoma of skin
+4
Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma
Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

Not recruiting

3 1 1
Investigated diseases:
- Cervix carcinoma
+6
Study on Flecainide to Reduce Risk of Atrial Arrhythmia After Patent Foramen Ovale Closure in Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Arrhythmia
Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- HER2 positive breast cancer
- Breast cancer metastatic
Study of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Not recruiting

3 1 1
Investigated diseases:
- Facial paresis
Study on the Effects of Amiloride and Sodium Chloride on Vascular Stiffness in Patients with Polycystic Kidney Disease

Not recruiting

3 1 1
Investigated diseases:
- Congenital cystic kidney disease
Study on the Safety and Effectiveness of Crinecerfont for Children with Classic Congenital Adrenal Hyperplasia

Not recruiting

3 1
Investigated diseases:
- Adrenogenital syndrome
+1
Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies